Skip to main content
padlock icon - secure page this page is secure

Development of selective immune tolerance towards the allogeneic fetus during pregnancy: Role of tryptophan catabolites (Review)

Buy Article:

$42.00 + tax (Refund Policy)

Studies in recent years have shown that the selective expression of indoleamine 2,3-dioxygenase (IDO) in certain cell populations may play an important role in mediating immunosuppression. Mechanistically, since IDO is a rate-limiting enzyme of the kynurenine pathway responsible for tryptophan catabolism, the prevailing explanation for its immunosuppressive action is based on the assumption that the presence of IDO in selected cell populations would consume local tryptophan and subsequently starve adjacent maternal T-cells of this essential amino acid. In this review, an alternative hypothesis is discussed, which suggests that IDO is mainly expressed in various types of antigen-presenting cells (such as placental syncytiotrophoblasts during pregnancy), and that its main function is to produce biologically-active tryptophan catabolites that will mediate immunosuppression. Mechanistically, because these tryptophan catabolites are concentrated in a microenvironment surrounding the IDO-expressing dendritic cells, they will selectively suppress the proliferation of a sub-population of T-cells that are activated by the allogeneic antigen-presenting cells and ultimately wipe out this T-cell sub-population. Evidence in support of this new mechanistic explanation is discussed. This hypothesis provides an alternative mechanistic explanation for the development of selective immune tolerance towards the allogeneic fetus during pregnancy. Moreover, it also offers insights into the functional role of certain tryptophan catabolites produced by cancer cells in evading the body's immune surveillance, as well as the potential usefulness of tryptophan catabolites as pharmacological agents for the induction of selective long-term immune tolerance towards the allogeneic organ transplant.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Research Article

Affiliations: Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA., Email: [email protected]

Publication date: June 1, 2010

More about this publication?
  • The International Journal of Molecular Medicine is a monthly, peer-reviewed journal devoted to the publication of high quality studies related to the molecular mechanisms of human disease. The journal welcomes research on all aspects of molecular and clinical research, ranging from biochemistry to immunology, pathology, genetics, human genomics, microbiology, molecular pathogenesis, molecular cardiology, molecular surgery and molecular psychology.

    The International Journal of Molecular Medicine aims to provide an insight for researchers within the community in regard to developing molecular tools and identifying molecular targets for the diagnosis and treatment of a diverse number of human diseases.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more